Literature DB >> 9766872

Fully automated high-performance liquid chromatography of ciprofloxacin with direct injection of plasma and Mueller-Hinton broth for pharmacokinetic/pharmacodynamic studies.

B B Ba1, D Ducint, M Fourtillan, M C Saux.   

Abstract

An isocratic high-performance liquid chromatographic method with column switching and direct injection has been developed to determine ciprofloxacin in plasma and Mueller-Hinton broth. An on-line dilution of the sample was performed with a loading mobile phase consisting of 173 mM phosphoric acid. The analyte was retained on a LiChrocart 4-4 precolumn filled with a LiChrospher 100 RP18, 5 microm. An electric-actuated system with two six-port valves allowed a clean-up step with a mixture 20 mM phosphate buffer (pH 3.5)-methanol (97:3, v/v) and the transfer of the analyte by a back-flush mode to a 150 x 4.6 mm I.D. column packed with a Kromasil C8 5 microm, using a mobile phase of 20 mM phosphate buffer (pH 3.5)-acetonitrile (85:15, v/v). Fluorescence detection allowed a quantification limit of 0.078 microg/ml with a 40-microl sample size. The method was evaluated to determine its usefulness in studying the pharmacokinetic/pharmacodynamic behaviour of ciprofloxacin in an in vitro model.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9766872     DOI: 10.1016/s0378-4347(98)00192-3

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  3 in total

1.  Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition.

Authors:  Simon N Muchohi; Nahashon Thuo; Japhet Karisa; Alex Muturi; Gilbert O Kokwaro; Kathryn Maitland
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-12-04       Impact factor: 3.205

2.  Evaluation of physicochemical properties as supporting information on quality control of raw materials and veterinary pharmaceutical formulations.

Authors:  Sara da Silva Anacleto; Marcella Matos Cordeiro Borges; Hanna Leijoto de Oliveira; Andressa Reis Vicente; Eduardo Costa de Figueiredo; Marcone Augusto Leal de Oliveira; Bárbara Juliana Pinheiro Borges; Marcelo Antonio de Oliveira; Warley de Souza Borges; Keyller Bastos Borges
Journal:  J Pharm Anal       Date:  2018-01-17

3.  Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model.

Authors:  Boubakar B Ba; Hala Feghali; Corinne Arpin; Marie-Claude Saux; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.